Your session is about to expire
← Back to Search
LFSD for Preventing Fatty Liver Disease in Children
Study Summary
This trial is testing if reducing dietary sugar intake can prevent NAFLD in Hispanic children before they reach puberty.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been part of a weight loss or obesity treatment program.I have a history of severe depression.I have been taking medication that can cause fatty liver for the past year.I have received a liver transplant.I have a chronic liver condition that is not NAFLD or 'fatty liver'.I have or had cancer.My BMI is in the top 50% for my age and gender.I am between 6 and 9 years old.I have type 2 diabetes with an A1c over 6.4%.My physical development is at the earliest puberty stage.
- Group 1: Usual Care Control
- Group 2: Low Free Sugar Diet (LFSD) Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has recruitment for this clinical experiment commenced?
"As displayed on clinicaltrials.gov, this medical trial is currently recruiting volunteers and has been since April 6th 2022. The details of the study have been recently modified as of April 12th 2022."
What is the current enrollment of this clinical experiment?
"That is accurate. Per the information on clinicaltrials.gov, this medical trial commenced recruitment efforts on April 6th 2022 and has recently been updated as of April 12th 2022. 200 individuals are needed from one site in particular."
What are the criteria for entry into this medical trial?
"This experiment seeks out 200 young individuals between the ages of 6 and 9, who have some form of liver illness. Applicants must be Hispanic or Latino (as reported by at least one parent or the child), with a BMI that is above the 85th percentile for their sex and age, Tanner stage 1 developmentally, normal ALT levels on screening labs, parental/legal guardian consent as well as assent from the child."
What are the main aims of this clinical experiment?
"This clinical trial has been designed to measure the progression of hepatic steatosis for 24 months since the start of intervention. Secondary objectives include alterations in GGT, HDL, and triglyceride levels which will be determined through laboratory testing."
Are individuals over 35 years of age being included in the trial?
"As detailed by the study's inclusion criteria, participants must fall between 6 and 9 years old. For younger individuals there are 33 clinical trials available while those aged 65+ have access to 320 different studies."
Share this study with friends
Copy Link
Messenger